Methadone
Disability linked to treatment rates for opioid use disorder
Among Medicaid beneficiaries with opioid use disorder, those with a disability were less likely to receive medication treatment and to adhere to treatment for 6 months, according to findings published in JAMA Network Open.
Buprenorphine-naloxone combo appears safe for treating opioid use disorder in pregnancy
Women receiving buprenorphine-naloxone therapy for the treatment of opioid use disorder during pregnancy had similar outcomes vs. buprenorphine therapy alone in terms of maternal and neonatal health, data show.
SAMHSA proposes permanent changes to OUD treatment, hoping to expand access
The Substance Abuse and Mental Health Services Administration is proposing permanent changes to federal rules that would allow take-home doses of methadone and greater use of telehealth, according to a press release.
Buprenorphine may be safer than methadone for opioid use disorder in pregnancy
New data published in The New England Journal of Medicine showed that buprenorphine use during pregnancy was associated with a lower risk for adverse neonatal outcomes compared with methadone use.
'A long way to go': Nearly 90% of people with opioid use disorder do not receive medication
The majority of people with opioid use disorder in the United States are not receiving life-saving medication due to multiple barriers to access, according to a study published in the International Journal of Drug Policy.
Overdose deaths during pandemic driven by fentanyl, not policy changes
An increase of methadone-involved overdose deaths beginning in March 2020 was linked to a rise in overdose deaths from illicitly made fentanyl, not policy changes for take-home methadone, data show.
Buprenorphine supply stable during pandemic, as methadone supply dropped
The buprenorphine supply in the United States has remained stable, while the methadone supply has consistently dropped during the COVID-19 pandemic, researchers reported in JAMA Network Open.
Barriers prevent pregnant women from accessing treatment for opioid overdose
SAN DIEGO — Medication-assisted treatment for opioid overdose remains largely inaccessible for pregnant women, according to research presented at the ACOG Annual Clinical and Scientific Meeting.
Study finds no link between take-home opioid agonist therapy, overdose risk
An increase in take-home doses of opioid agonist therapy early in the COVID-19 pandemic was associated with lower rates of treatment interruption and did not increase the risk for opioid-related overdoses, according to a recent study.
Office-based treatment may enhance methadone access for those with opioid use disorder
Using methadone to treat opioid use disorder in office-based settings may enhance access to this treatment without adversely affecting patient outcomes, according to results of a scoping review published in American Journal of Psychiatry.